The clinical application of linagliptin in Asians

Asia has a growing diabetic population. Linagliptin, a member of dipeptidyl peptidase-4 inhibitor class, is unique in its nonlinear pharmacokinetics with the characteristics of rapid attainment of steady state, little accumulation, predominantly nonrenal route of elimination, prolonged terminal half...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chu-qing, Xiang, Yu-fei, Zhou, Zhi-guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577268/
https://www.ncbi.nlm.nih.gov/pubmed/26396526
http://dx.doi.org/10.2147/TCRM.S64402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577268/
https://www.ncbi.nlm.nih.gov/pubmed/26396526
http://dx.doi.org/10.2147/TCRM.S64402

Ejemplares similares